Parallel trade in Europe has attracted the gimlet eye of antitrust regulators. EU investigators launched a probe into...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
DRUG MARKETING
Pharmaceutical companies are bombarding the airwaves with TV ads, showering doctors with gifts to get them to prescribe more of their drugs, and practicing other marketing tactics that can get them into hot water. The topic of drug marketing will examine the myriad ways the industry pushes its products -- and the inevitable controversies that result.
Drug Marketing is part of Business Exchange, suggested by
Arlene Weintraub.
This topic contains
408 news
and
218 blog
items.
Read updated news, blogs, and resources about Drug Marketing. Find user-submitted articles and reactions on Drug Marketing from
like-minded professionals.
Blogs
Recent blog posts on this topic.
An appeal being heard today on a case seen as the precursor to the mountains of litigation over Johnson & Johnson's...
Oncology drugs are hot. Scratch beneath the surface of most major drugmakers, and you'll find a host of them in various...
In a bid to tighten its voluntary code of practice, the Association of the British Pharmaceutical Industry has proposed...
The pharma industry's promotional practices are under scrutiny once again. This time, the spotlighted products are...
Good morning, folks. How are you today? Some gloomy clouds are hovering over the Pharmalot corporate campus, but these...
Good morning, everyone, and nice to see you again. We hope the weekend was refreshing. As for us, we are back from a...
Last week, Advertising Age celebrated a big direct-to-consumer ad campaign that's in the works for Purdue Pharma's new...
After a series of ad agency shuffles over the past several years, Pfizer ($PFE) is conducting an overall review of its...
The good news: New drugs do push up drug spending. At least that was the case in 2011, when U.S. spending on...
“Ever dropped a bell on a nun, ripped the armpit hair off an old man or stuffed a live lobster down a loved one’s...
Call it the French retrench. After two years of no growth, the drug market in France is projected to shrink 1% to 2%,...
After announcing the tie-up almost a year ago, India's Dr. Reddy's Laboratories ($RDY) finally expects to ink a joint...
We sound like a broken record when it comes to Valeant Pharmaceuticals ($VRX): The Canadian drugmaker has made yet...
India and China are on most expansion-minded drugmakers' shopping lists. So, it's not a huge surprise that top Japanese...
India's Dr. Reddy's Laboratories plans to go shopping in Russia. The generics specialist wants to expand its portfolio...
There is certainly nothing surprising that Pfizer or any other large drugmaker is planning to cut jobs.
Johnson & Johnson's ($JNJ) legion of legal problems is one less strong. The company agreed to pay $85 million and...
Top of the morning to you. We have just returned from one of the local schoolhouses, where we have deposited a sleepy...
South Africa's Aspen Pharmacare has posted some strong full-year sales and profits growth, thanks in part to expansion...
Is this surprising? A new study finds that 39 percent of the public mistakenly believes that the FDA approves only...
Three Democratic members of the US House are pressing the US Federal Trade Commission to conduct an in-depth analysis...
Johnson & Johnson ($JNJ) CEO Bill Weldon (photo) is the highest-paid Big Pharma chief, no question. His $28.
Biogen Idec ($BIIB) is taking its multiple sclerosis marketing in house. The Massachusetts-based company has bought out...
Emerging markets continue to beckon Big Pharma. Eli Lilly ($LLY) is in partnership talks with Turkey's Mustafa Nevzat...
Top Sources: Drug Marketing
- medicinesocialjustice.blogspot.com
- News
- blogs.nature.com
- carlatpsychiatry.blogspot.com
- doseofdigital.com
- drugreptoys.blogspot.com
- CNBC
- eyeonfda.com
- pharmamkting.blogspot.com
- drugchannels.net
account